Rizatriptan Benzoate Tablet
Product Images NDC 61919-656

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 61919-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

394 (394 18)

Packaging label for Rizatriptan Benzoate 5 mg oral tablets, 18 tablets per bottle. The label states it is generic for Maxalt, with each tablet containing 7.265 mg of rizatriptan benzoate equivalent to 5 mg of rizatriptan. The labeler is Direct RX, distributed in Alpharetta, GA. Lot number and expiration date fields are also visible.*

FDA Label Image

656 12

Label of Rizatriptan Benzoate 10 mg oral tablets, featuring a 12-tab count. The label notes it is generic for Maxalt, with each tablet containing 14.53 mg of rizatriptan benzoate USP equivalent to 10 mg rizatriptan. Packaged and distributed by Direct RX in Alpharetta, GA. Includes lot number, expiration date (07/20), and NDC 61919-656-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.